Mochida Pharmaceutical Co., Ltd.'s total assets for Q4 2024 were ¥160.12B, a decrease of -3.57% from the previous quarter. DE:MFY total liabilities were ¥29.43B for the fiscal quarter, a -17.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.